These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25609257)

  • 1. Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils.
    Mao Y; Teoh CL; Yang S; Zlatic CO; Rosenes ZK; Gooley PR; Howlett GJ; Griffin MD
    Biochemistry; 2015 Feb; 54(6):1421-8. PubMed ID: 25609257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II.
    Mao Y; Zlatic CO; Griffin MD; Howlett GJ; Todorova N; Yarovsky I; Gooley PR
    Biochemistry; 2015 Aug; 54(31):4805-14. PubMed ID: 26196342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and Intersubunit Ion-Pair Interactions Determine the Ability of Apolipoprotein C-II Mutants To Form Hybrid Amyloid Fibrils.
    Todorova N; Zlatic CO; Mao Y; Yarovsky I; Howlett GJ; Gooley PR; Griffin MD
    Biochemistry; 2017 Mar; 56(12):1757-1767. PubMed ID: 28229588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution Conditions Affect the Ability of the K30D Mutation To Prevent Amyloid Fibril Formation by Apolipoprotein C-II: Insights from Experiments and Theoretical Simulations.
    Mao Y; Todorova N; Zlatic CO; Gooley PR; Griffin MD; Howlett GJ; Yarovsky I
    Biochemistry; 2016 Jul; 55(27):3815-24. PubMed ID: 27311794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrils.
    Zlatic CO; Mao Y; Todorova N; Mok YF; Howlett GJ; Yarovsky I; Gooley PR; Griffin MDW
    FEBS J; 2018 Aug; 285(15):2799-2812. PubMed ID: 29791776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
    Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
    J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
    Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
    Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of polymorphism in apolipoprotein C-II amyloid fibrils.
    Teoh CL; Yagi H; Griffin MD; Goto Y; Howlett GJ
    J Biochem; 2011 Jan; 149(1):67-74. PubMed ID: 20889492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation.
    Teoh CL; Bekard IB; Asimakis P; Griffin MD; Ryan TM; Dunstan DE; Howlett GJ
    Biochemistry; 2011 May; 50(19):4046-57. PubMed ID: 21476595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
    Legge FS; Binger KJ; Griffin MD; Howlett GJ; Scanlon D; Treutlein H; Yarovsky I
    J Phys Chem B; 2009 Oct; 113(42):14006-14. PubMed ID: 19780547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
    Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
    Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils.
    Binger KJ; Ecroyd H; Yang S; Carver JA; Howlett GJ; Griffin MD
    FASEB J; 2013 Mar; 27(3):1214-22. PubMed ID: 23159935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
    Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
    J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations.
    Teoh CL; Pham CL; Todorova N; Hung A; Lincoln CN; Lees E; Lam YH; Binger KJ; Thomson NH; Radford SE; Smith TA; Müller SA; Engel A; Griffin MD; Yarovsky I; Gooley PR; Howlett GJ
    J Mol Biol; 2011 Feb; 405(5):1246-66. PubMed ID: 21146539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide.
    Todorova N; Hung A; Maaser SM; Griffin MD; Karas J; Howlett GJ; Yarovsky I
    Phys Chem Chem Phys; 2010 Nov; 12(44):14762-74. PubMed ID: 20938536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils.
    Binger KJ; Griffin MD; Howlett GJ
    Biochemistry; 2008 Sep; 47(38):10208-17. PubMed ID: 18729385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
    Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
    J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II.
    Ryan TM; Howlett GJ; Bailey MF
    J Biol Chem; 2008 Dec; 283(50):35118-28. PubMed ID: 18852267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An equilibrium model for linear and closed-loop amyloid fibril formation.
    Yang S; Griffin MD; Binger KJ; Schuck P; Howlett GJ
    J Mol Biol; 2012 Aug; 421(2-3):364-77. PubMed ID: 22370559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.